Nalaganje...

The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study

Coronavirus disease 2019 (COVID-19) is associated with abnormal hemostasis, autopsy evidence of systemic microthrombosis, and a high prevalence of venous thromboembolic disease. Tissue plasminogen activator (tPA) has been used in patients with critically ill COVID-19 with high clinical suspicion of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thromb Thrombolysis
Main Authors: So, Matsuo, Steiger, David J., Takahashi, Mai, Egorova, Natalia N., Kuno, Toshiki
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2021
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106515/
https://ncbi.nlm.nih.gov/pubmed/33966157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-021-02477-5
Oznake: Označite
Brez oznak, prvi označite!